BIOBIJOU Statistics
Total Valuation
BIOBIJOU has a market cap or net worth of KRW 245.83 billion. The enterprise value is 211.86 billion.
Market Cap | 245.83B |
Enterprise Value | 211.86B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BIOBIJOU has 15.04 million shares outstanding.
Current Share Class | 15.04M |
Shares Outstanding | 15.04M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +6.34% |
Owned by Insiders (%) | 8.97% |
Owned by Institutions (%) | 4.61% |
Float | 5.11M |
Valuation Ratios
The trailing PE ratio is 25.84.
PE Ratio | 25.84 |
Forward PE | n/a |
PS Ratio | 7.23 |
PB Ratio | 4.02 |
P/TBV Ratio | 4.03 |
P/FCF Ratio | 41.73 |
P/OCF Ratio | 40.32 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.71, with an EV/FCF ratio of 35.97.
EV / Earnings | 27.11 |
EV / Sales | 6.23 |
EV / EBITDA | 19.71 |
EV / EBIT | 21.20 |
EV / FCF | 35.97 |
Financial Position
The company has a current ratio of 14.30, with a Debt / Equity ratio of 0.01.
Current Ratio | 14.30 |
Quick Ratio | 12.68 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.04 |
Debt / FCF | 0.07 |
Interest Coverage | 68.72 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 16.28% |
Revenue Per Employee | 944.47M |
Profits Per Employee | 217.07M |
Employee Count | 36 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BIOBIJOU has paid 1.85 billion in taxes.
Income Tax | 1.85B |
Effective Tax Rate | 19.14% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 17,855.40 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 45.63 |
Average Volume (20 Days) | 141,621 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOBIJOU had revenue of KRW 34.00 billion and earned 7.81 billion in profits. Earnings per share was 632.31.
Revenue | 34.00B |
Gross Profit | 17.85B |
Operating Income | 9.99B |
Pretax Income | 9.66B |
Net Income | 7.81B |
EBITDA | 10.75B |
EBIT | 9.99B |
Earnings Per Share (EPS) | 632.31 |
Balance Sheet
The company has 34.39 billion in cash and 424.73 million in debt, giving a net cash position of 33.96 billion or 2,257.40 per share.
Cash & Cash Equivalents | 34.39B |
Total Debt | 424.73M |
Net Cash | 33.96B |
Net Cash Per Share | 2,257.40 |
Equity (Book Value) | 61.21B |
Book Value Per Share | 4,068.68 |
Working Capital | 48.79B |
Cash Flow
In the last 12 months, operating cash flow was 6.10 billion and capital expenditures -206.18 million, giving a free cash flow of 5.89 billion.
Operating Cash Flow | 6.10B |
Capital Expenditures | -206.18M |
Free Cash Flow | 5.89B |
FCF Per Share | 391.55 |
Margins
Gross margin is 52.50%, with operating and profit margins of 29.39% and 22.98%.
Gross Margin | 52.50% |
Operating Margin | 29.39% |
Pretax Margin | 28.42% |
Profit Margin | 22.98% |
EBITDA Margin | 31.61% |
EBIT Margin | 29.39% |
FCF Margin | 17.33% |
Dividends & Yields
BIOBIJOU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 3.18% |
FCF Yield | 2.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BIOBIJOU has an Altman Z-Score of 44.36 and a Piotroski F-Score of 2.
Altman Z-Score | 44.36 |
Piotroski F-Score | 2 |